1981
DOI: 10.1007/bf00915474
|View full text |Cite
|
Sign up to set email alerts
|

Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome

Abstract: The results of a nationwide survey on primary immunodeficiency syndrome (PIS) in Japan are presented. By the repeated questionnaire method, 497 PIS cases were collected prior to February 1979 with clinical information. Numbers of each type of PIS, age at the time of diagnosis, patient's status at the time of registration, familial incidence of PIS, and development of malignancy, autoimmune diseases, and allergic diseases among all reported patients are presented and discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
55
0
2

Year Published

1986
1986
2014
2014

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 108 publications
(62 citation statements)
references
References 3 publications
5
55
0
2
Order By: Relevance
“…Also, despite apparent health in most IgA-deficient patients, there is an increased incidence of autoimmune disease among IgAdeficient individuals (28,29). Thus, we plan to follow the clinical status of these apparently healthy children with subnormal IgG2 levels over a longer period of time.…”
Section: Resultsmentioning
confidence: 99%
“…Also, despite apparent health in most IgA-deficient patients, there is an increased incidence of autoimmune disease among IgAdeficient individuals (28,29). Thus, we plan to follow the clinical status of these apparently healthy children with subnormal IgG2 levels over a longer period of time.…”
Section: Resultsmentioning
confidence: 99%
“…Whereas there have been estimates of these parameters from geographically limited studies [4,8,11,13,21,26]; those estimates were based on diagnosed cases. The number of undiagnosed cases is not known because there is no population-based screening process for PID anywhere in the world at any time during life.…”
Section: Discussionmentioning
confidence: 99%
“…therapy may appear to be of little general importance. However, if the number of individuals affected by XLA (0.5 to 1 per million [4,29,41,65]) and CVID (about 0.5 to 1 per 100,000 [4,29,41,65]) is taken into account, it is safe to state that the incidence of severe viral manifestations, such as encephalitis, was considerably higher in these patients than in the general population, even when enterovirus infections are excluded. For instance, in the years of i.m.…”
Section: The Scripps Research Institute La Jolla California 92037mentioning
confidence: 99%